↓ Skip to main content

Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug

Overview of attention for article published in Revista da Associação Médica Brasileira, January 2003
Altmetric Badge

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug
Published in
Revista da Associação Médica Brasileira, January 2003
DOI 10.1590/s0104-42302003000100041
Pubmed ID
Authors

Larissa de Godoy Borges, Pedro Eduardo Fröehlich

Abstract

The new uses of thalidomide are reviewed. It has recently been used as antinflammatory, immunosuppressive, antiangiogenic, and antiviral agent. Although its mechanism of action is not yet understood, the advantage of its use in several diseases, such as erythema nodosum leprosum, multiple myeloma, and graft-versus-host-disease is evident. Owing to its teratogenic properties, the use of thalidomide must be very well controlled. However, thalidomide has become a very important alternative, with new applications being studied.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 25%
Researcher 1 25%
Other 1 25%
Student > Doctoral Student 1 25%
Readers by discipline Count As %
Medicine and Dentistry 4 100%